Trauma and psychotic experiences: transnational data from the World Mental Health Survey.

Journal: The British journal of psychiatry : the journal of mental science

Volume: 211

Issue: 6

Year of Publication: 2018

Affiliated Institutions:  John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology - LIM , Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) - St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S , Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA j.mcgrath@uq.edu.au. John J. McGrath, MD, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, and National Centre for Register-based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark; Sukanta Saha, PhD, Queensland Centre for Mental Health Research, and Queensland Brain Institute, University of Queensland, Australia; Carmen C. W. Lim, MSc, Queensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia; Sergio Aguilar-Gaxiola, MD, PhD, Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California, USA; Jordi Alonso, MD, PhD, Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain, Pompeu Fabra University (UPF), Barcelona, Spain and CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Laura H. Andrade, MD, PhD, Section of Psychiatric Epidemiology - LIM , Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; Evelyn J. Bromet, PhD, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA; Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium; José M. Caldas de Almeida, MD, PhD, Chronic Diseases Research Center (CEDOC) and Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, (Campo dos Mártires da Pátria), Lisbon, Portugal; Graça Cardoso, MD, PhD, Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), Nova Medical School, Universidade Nova de Lisboa, Lisboa, Portugal; Giovanni de Girolamo, MD, Unit of Epidemiological and Evaluation Psychiatry, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) - St. John of God Clinical Research Centre, Brescia, Italy; John Fayyad, MD, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon; Silvia Florescu, MD, PhD, National School of Public Health, Management and Professional Development, Bucharest, Romania; Oye Gureje, MD, DSc, FRCPsych, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Josep M. Haro, MD, PhD, Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; Norito Kawakami, MD, DMSc, Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan; Karestan C. Koenen, PhD, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Viviane Kovess-Masfety, MD, PhD, Ecole des Hautes Etudes en Santé Publique (EHESP), EA Paris Descartes University, Paris, France; Sing Lee, MBBS, Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong; Jean-Pierre Lepine, MD, Hôpital Lariboisière- Fernand widal, Assistance Publique Hôpitaux de Paris, Universités Paris Descartes-Paris Diderot and INSERM UMR-S , Paris, France; Katie A. McLaughlin, PhD, Department of Psychology, University of Washington, Seattle, Washington, USA; Maria E. Medina-Mora, PhD, National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico; Fernando Navarro-Mateu, MD, PhD, IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano delusional experiences Salud, El Palmar (Murcia), Spain; Akin Ojagbemi, PhD, College of Medicine, University of Ibadan; University College Hospital, Ibadan, Nigeria; Jose Posada-villa, MD, Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia; Nancy Sampson, BA, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA; Kate M. Scott, PhD, Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand; Hisateru Tachimori, PhD, National Institute of Mental Health, National Center for Neurology and Psychiatry, Tokyo, Japan; Margreet ten Have, PhD, Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Netherlands; Kenneth S. Kendler, MD, Department of Psychiatry, Virginia Commonwealth University, USA; Ronald C. Kessler, PhD, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.

Abstract summary 

Traumatic events are associated with increased risk of psychotic experiences, but it is unclear whether this association is explained by mental disorders prior to psychotic experience onset.To investigate the associations between traumatic events and subsequent psychotic experience onset after adjusting for post-traumatic stress disorder and other mental disorders.We assessed 29 traumatic event types and psychotic experiences from the World Mental Health surveys and examined the associations of traumatic events with subsequent psychotic experience onset with and without adjustments for mental disorders.Respondents with any traumatic events had three times the odds of other respondents of subsequently developing psychotic experiences (OR = 3.1, 95% CI 2.7-3.7), with variability in strength of association across traumatic event types. These associations persisted after adjustment for mental disorders.Exposure to traumatic events predicts subsequent onset of psychotic experiences even after adjusting for comorbid mental disorders.

Authors & Co-authors:  McGrath John J JJ Saha Sukanta S Lim Carmen C W CCW Aguilar-Gaxiola Sergio S Alonso Jordi J Andrade Laura H LH Bromet Evelyn J EJ Bruffaerts Ronny R Caldas de Almeida José M JM Cardoso Graça G de Girolamo Giovanni G Fayyad John J Florescu Silvia S Gureje Oye O Haro Josep M JM Kawakami Norito N Koenen Karestan C KC Kovess-Masfety Viviane V Lee Sing S Lepine Jean-Pierre JP McLaughlin Katie A KA Medina-Mora Maria E ME Navarro-Mateu Fernando F Ojagbemi Akin A Posada-Villa Jose J Sampson Nancy N Scott Kate M KM Tachimori Hisateru H Ten Have Margreet M Kendler Kenneth S KS Kessler Ronald C RC

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Trotta A, Murray RM, Fisher HL. The impact of childhood adversity on the persistence of psychotic symptoms: a systematic review and meta-analysis. Psychol Med 2015; 45: 2481–98.
Authors :  32
Identifiers
Doi : 10.1192/bjp.bp.117.205955
SSN : 1472-1465
Study Population
Male,Female
Mesh Terms
Comorbidity
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
England